Skip to main content

Table 1 Demographic and Clinical characteristics and outcomes of males on ART screened for gynecomastia (N = 1432)

From: Gynecomastia in HIV-positive adult men receiving efavirenz-based antiretroviral therapy at Newlands clinic, Harare, Zimbabwe

Characteristic

All (N = 1432)

Gynecomastia (n = 73)

Demographics

 Age (years), median (IQR)

40 (38–48)

40 (33–48)

 Baseline CD4 count median (IQR)

260 (126–412)

318 (192–469)

 Baseline BMI, median (IQR)

21 (19–24)

21 (19–23)

 Baseline WHO (%)

  Stage 1

548 (50)

28 (48)

  Stage 2

217 (20)

14 (24)

  Stage 3

233 (21)

10 (17)

  Stage 4

97 (9)

6 (10)

  Follow up time (years), median (IQR)

1.7 (1.0–2.6)

 

Presentation of gynecomastia

 Unilateral

 

28 (38)

 Bilateral

 

43 (59)

 Unknown

 

2 (3)

Outcomes

 Complete resolution

 

28 (38)

 Partial resolution

 

43 (59)

 Non resolution

 

2 (3)

 Unknown

 

5 (7)

  1. IQR interquartile range, WHO World Health Organization Staging